Notable Analyst Rating Changes 6/9: X, CSX, OMTR, MRVL Higher; HIG, VRX, MAS Lower
More News related to ATHN
- Raymond James Upgrades athenahealth (ATHN) to Outperform
- Auriga Upgrades athenahealth (ATHN) to Hold; Raises FY10-11 Estimates
- After-Hours Movers 10/29: AXTI, ISSI, APKT, GNW, CEC, CSA, LVS Higher; IDIX, NVTL, TSRA, CRDC Lower
- Athenahealth, Inc. (ATHN) Posts Q3 EPS of $0.14, Revs In-Line
- athenahealth, Inc. Reports Third Quarter 2009 Results
More News related to CSX
- CSXT Continues to Invest in New Technology to Drive Efficiency and a Reduction in Emissions
- CSX and City Year Send 150 Volunteers to Charleston for "Give a Day, Change the World"
- CSX Becomes First Transportation Provider to Join Maryland Green Registry
- CSX Corporation Chief Transportation Officer to Address Citi Investment Research Transportation Conference
- Notable Analyst Rating Changes: CSX, UNH, DF, TS Upgraded; SNDK, INTC, VALE Upgraded
More News related to HIG
- The Hartford Launches Voluntary Benefits Solution That Removes Administration Burden For Employers, Workers
- After-Hours Movers 11/03: QLTY, PACR, BGCP, TESO Higher; STEC, TRLG, CLRT, CRL, MYGN Lower
- Hartford Financial (HIG) Delivers Rare Beat and Raise Q3
- Hartford Financial (HIG) Tops Q3 EPS by 45c; Guides Up
- The Hartford Announces Third Quarter 2009 Results
More News related to Special Reports
- Hemispherx Biopharma (HEB) Reports a Q3 Loss; Comments on FDA Responses
- Wright Medical Group (WMGI) Announces FDA Approval For CONSERVE Plus Total Hip Resurfacing System
- Vascular Solutions (VASC) Receives 501(k) Clearance from U.S. FDA for GuideLiner Catheter
- Glaxo (GSK) and XenoPort (XNPT) Announed that U.S. FDA Has Extended the Review Date of GSK1838262/XP13512
- Compugen (CGEN) Announces Discovery of Biomarker CGEN-40001 for Type 2 Diabetes
UPGRADES:
Morgan Stanley upgrades U.S. Steel (NYSE: X) from Equal-weight to Overweight.
Goldman Sachs upgrades CSX Corp. (NYSE: CSX) from Neutral to Buy and raises their price target from $36 to $40.
Morgan Stanley upgrades Omniture (Nasdaq: OMTR) from Equalweight to Overweight. Click here to see full color on the upgrade.
JMP Securities upgrades Marvell Technology (Nasdaq: MRVL) from Underperform to Outperform.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citigroup downgrades Hartford Financial (NYSE: HIG) from Buy to Hold and lowers their price target from $21 to $19, citing a management vacuum after Chairman/CEO Ayer announced plans to retire.
Wachovia downgrades Valeant Pharmaceuticals (NYSE: VRX) to Underperform. Valuation Range: $15 to $17. Click here for the full report.
UBS downgrades Masco (NYSE: MAS) from Neutral to Sell.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Sanford C. Bernstein initiates coverage on State Street (NYSE: STT) with an Outperform rating.
Brean Murray Initiates Coverage on athenahealth (Nasdaq: ATHN) with a Buy. Click here for more color on the coverage.
J.P. Morgan initiates coverage on CarMax (NYSE: KMX) with a Neutral rating. Price target $15.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
+0.56Related Entities
- Brean Murray Carret & Co.
- UBS
- JPMorgan
- Goldman Sachs
- Citi
- Morgan Stanley
- Wachovia
- Sanford C. Bernstein
- JMP Securities
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
